Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner

Clinical Immunology and Immunopathology

Volumn 67, Issue 2, 1993, Pages 130-136

  Mojcik, Christopher F ^a   Gourley, Mark F ^a   Klinman, Dennis M ^a,b   Krieg, Arthur M ^a   Gmelig Meyling, Frits ^a   Steinberg, Alfred D ^a,c  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c MITRE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0027308946     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1993.1055     Document Type: Article

References (37)

1. Alberto, B. P., Callagan, L. F., and Pincus, T., Evidence that retrovirus expression in mouse spleen cells results from B cell differentiation. J. Immunol. 129, 2768, 1982.
2. Krieg, A. M., and Steinberg, A. D., Retroviruses and autoimmunity, J. Autoimmun. 3, 137, 1990.
3. Krieg, A. M., Khan, A. S., and Steinberg, A. D., Multiple endogenous xenotropic and mink cell focus-forming murine leukemia virus-related transcripts are induced by polyclonal immune activators. J. Virol. 62, 3545, 1988.
4. a expressing cells. Nature. 339, 541, 1989.
5. Janeway, C., Mis: Makes little sense. Nature. 349, 459, 1991.
6. Frankel, W. N., Rudy, C., Coffin, J. M., and Huber, B. T., Linkage of Mis genes to endogenous mammary tumor viruses of inbred mice. Nature. 349, 526, 1991.
7. Dyson, P. J., Knight, A. M., Fairchild, S., Limson, E., and Tomonari, K., Genes encoding ligands for deletion of V011 T cells cosegregate with mammary tumor vims genomes. Nature. 349, 531, 1991.
8. Tsichles, P. N., and Bear, S. E., Infection by mink cell focus forming viruses confers interleukin 2 (IL-2) independence to an IL-2 dependent rat T-cell lymphoma line. Proc. Natl. Acad. Set. USA. 83, 4611, 1991.
9. Li, J. P., and Baltimore, D., Mechanisms of leukemogenesis induced by mink cell focus-forming murine leukemia viruses. J. Virol. 65, 2408, 1991.
10. Mathes, L. E., Olsen, R. G., Hebebrand, L. C., Hoover, E. A., and Schaller, J. P., Abrogation of lymphocyte blastogenesis by a feline leukemia virus protein. Nature. 274, 687, 1978.
11. Hebebrand, L. C., Olsen, R. G., Mathes, L. E., and Nichols, W. S., Inhibition of human lymphocyte mitogen and antigen response by a 15, 000 dalton protein from feline leukemia virus. Cancer Res. 39, 443, 1979.
12. Orosz, C. G., Zinn, N. E., Olsen, R. G., and Mathes, L. E., Retrovirus-mediated immunosuppression. II. Fe LV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion. J. Immunol. 135, 583, 1985.
13. Krieg, A. M., Gause, W. C., Gourley, M. F., and Steinberg, A. D., A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J. Immunol. 143, 2448, 1989
14. Goodchild, J., Inhibition of gene expression by oligonucleotides. In "Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression" (J. S. Cohen, Ed.), pp. 53-77, CRC Press, Boca Raton, FL, 1989.
15. Marcus-Sekura, C. J., Techniques for using antisense oligodeoxyribonucleotides to study gene expression. Anal. Biochem. 172, 289, 1988.
16. Zon, G., Oligonucleotide analogues as potential chemotherapeutic agents. Pharmacol. Res. 5, 539, 1988.
17. Stein, C. A., and Cohen, J. S., Oligodeoxynucleotides as inhibitors of gene expression: A review. Cancer Res. 48, 2659, 1988.
18. Stein, C. A., and Cohen, J. S., Phosphorothioate oligodeoxynucleotide analogues. In "Oligodeoxynucleotides; Antisense Inhibitors of Gene Expression" (J. S. Cohen, Ed.), pp. 97-117, CRC Press, Boca Raton, FL, 1989.
19. Campbell, J. M., Bacon, T. A., and Wickstrom, E., Oligodeoxynucleoside phosphorothioate stability in subcell ular extracts, culture media, sera and cerebrospinal fluid. J. Biochem. Biophys. Met. 20, 259, 1990.
20. Stein, C. A., Subasinghe, C., Shinozuka, K., and Cohen, J. S., Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acidsiies. 16, 3209, 1988.
21. Agrawal, S., Temsamani, J., and Tang, J. Y., Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA. 88, 7595, 1991.
22. De Clercq, E., Eckstein, F., Sternbach, H., and Merigan, T. C., The antiviral activity of thiophosphate-substituted polyribonucleotides in vitro and in vivo. Virology. 42, 421, 1970.
23. Le Doan, T., Chavany, C., and Helene, C., Antisense oligonucleotides as potential antiviral and anticancer agents. Bull. Cancer. 76, 849, 1989.
24. Leonetti, J.-P., Machy, P., Degols, G., Lebleu, B., and Leserman, L., Antibody-targeted liposomes containing oligodeoxyribonu-Received September 2, 1992; accepted with revision January 11, 1993 cleotides complementary to viral RNA selectively inhibit viral replication. Proc. Natl. Acad. Sc L USA 87, 2448, 1990.
25. Goodchild, J., Agrawal, S., Sarin, P., Letsinger, R. L., and Zamecnik, P. C., Antisense agents complementary to human immunodeficiency virus. In "Antisense RNA and DNA" (D. A. Melton, Ed.) Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988.
26. Matsukura, M., Shenozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J. S., and Broder, S., Phosphorothioate analogs of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 84, 7706, 1987.
27. Agrawal, S., Ikeuchi, T., Sun, D., Sarin, P. S., Konopka, A., Maizel, J., and Zamecnik, P. C., Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc. Natl. Acad. Sci. USA. 86, 7790, 1989.
28. Agrawal, S., Goodchild, J., Civeira, M., Sarin, P. S., and Zamecnik, P. C., Phosphoramidate, phosphorothioate, and methylphosphonate analogs of oligodeoxynucleotide: Inhibitors of replication of human immunodeficiency virus. Nucleosides Nucleotides. 8, 819, 1989.
29. Robinson-Benion, C., Kamata, N., and Holt, J. T., Antisense mapping of the c-fos promoter: Role of the serum response element. Antisense Res. Dev. 1, 21, 1991.
30. Kulka, M., Smith, C. C., Aurelian, L., Fishelevich, R., Meade, K., Miller, P., and Ts’o, P. O. P., Site specificity of the inhibitory effects of oligo(nucleoside methylphosohonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early m RNA 4. Proc. Natl. Acad. Sci. USA. 86, 6868, 1989.
31. Conrad, D. H., Ben-Sasson, S. Z., Le Gros, G., Finkelman, F. D., and Paul, W. E., Infection with Nippostrongylus Brasiliensis or injection of anti-Ig D antibodies markedly enhances Fc-receptormediated interleukin 4 production by non-B, non-T cells. J. Exp. Med. 171, 1497, 1990.
32. Krieg, A. M., Gmelig-Meyling, F., Gourley, M. F., Kisch, W. J., Chrisey, L. A., and Steinberg, A. D., Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res. Dev. 1, 161, 1991.
33. Steinberg, A. D., Krieg, A. M., Gourley, M. F., and Klinman, D. M., Theoretical and experimental approaches to generalized autoimmunity. Immunol. Rev. 118, 129, 1990.
34. Kastner, D. L., and Steinberg, A. D., Determinants of B cell hyperactivity in murine lupus. Concepts Immunopatho L. 6, 22, 1988.
35. Ruegg, C. L., Monell, C. R., and Strand M., Identification, using synthetic peptides of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T lymphotropic virus types I and II. J. Virol. 63, 3250, 1989.
36. Tschilis, P. N., and Lazo, P. A., Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr. Top. Microbiol. Immunol. 171, 95, 1991.
37. Hunter, E., and Swanstrom, R., Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157, 187, 1990.